S. R. Aravind

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

Roseanne O. Yeung, Yuying Zhang, Andrea O. Y. Luk et al. · The Lancet Diabetes & Endocrinology · 2014 · 302 citations

Medicine, Endocrinology, Adolescent Health +12

Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study

S. R. Aravind, Khaled Al Tayeb, Shaiful Bahari Ismail et al. · Current Medical Research and Opinion · 2011 · 85 citations

Medicine, Endocrinology, Internal Medicine +16

Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study

S. R. Aravind, Shaiful Bahari Ismail, Jugal Bihari Gupta et al. · Current Medical Research and Opinion · 2012 · 74 citations

Medicine, Endocrinology, Pharmacotherapy +15

Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial

Mala Dharmalingam, S. R. Aravind, Hemant Thacker et al. · Drugs · 2020 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Barriers to changing dietary behavior.

Kavita Kapur, Anil Kapur, Shobhana Ramachandran et al. · PubMed · 2008 · 49 citations

Public Health, Health Behavior, Nutrition +17